Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 754.80
+3.50 (0.47%)
At close: Jul 10, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 425.04 billion as of July 13, 2026.
Market Cap
425.04B
Enterprise Value
416.20B
Revenue
21.29B
Ranking
n/a
PE Ratio
71.82
Stock Price
754.80
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 425.04B, an increase of 3.63%. That is a compound annual growth rate of 3.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 425.04B | 16.17% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mphasis | 442.99B |
| NLC India | 436.37B |
| Authum Investment & Infrastructure | 436.29B |
| Balkrishna Industries | 435.72B |
| Welspun Corp | 423.87B |
| J.K. Cement | 417.14B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| 3M India | 398.30B |